{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:34:40Z","timestamp":1759412080768,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","funder":[{"name":"Ministry of Health, Labor and Welfare"},{"DOI":"10.13039\/100007843","name":"Norwegian Agency for Development Cooperation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Infect Dis."],"DOI":"10.1093\/infdis\/jiw492","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T15:06:02Z","timestamp":1476543962000},"page":"jiw492","source":"Crossref","is-referenced-by-count":7,"title":["Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial"],"prefix":"10.1093","author":[{"given":"Sonia","family":"Resik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Tejeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Okayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Sein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie A.","family":"Molodecky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magile","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilda","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai Heng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenisleydis","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"2017011017160970000_jiw492v1.1","unstructured":"Polio eradication and endgame strategic plan 2013\u20132018. Geneva: Global Polio Eradication Initiative, 2013 . http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf. Accessed 21 November 2016."},{"key":"2017011017160970000_jiw492v1.2","unstructured":"World Health Organization (WHO). Global Wild Poliovirus 2011\u20132016. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/11\/WPV_2011-2016_15Nov.pdf. Accessed 21 November 2016."},{"key":"2017011017160970000_jiw492v1.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.779"},{"key":"2017011017160970000_jiw492v1.4","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0140"},{"key":"2017011017160970000_jiw492v1.5","unstructured":"World Health Organization (WHO). Position paper on poliovirus vaccines. Geneva: WHO, 2016. http:\/\/www.who.int\/wer\/2016\/wer9112.pdf?ua=1 . Accessed 7 June 2016."},{"key":"2017011017160970000_jiw492v1.6","unstructured":"World Health Organization. Framework for national policy makers in OPV-using countries. 2015. Geneva: WHO, 2015. http:\/\/www.polioeradication.org\/content\/publications\/opvcessationframeworkenglish.pdf . Accessed 10 July 2016."},{"key":"2017011017160970000_jiw492v1.7","unstructured":"Advisory Committee on Poliomyelitis Eradication\u2014conclusions and recommendations. Geneva: WHO. 2007. http:\/\/www.who.int\/wer\/2008\/wer8303.pdf?ua=1 . Accessed 10 July 2016."},{"key":"2017011017160970000_jiw492v1.8","unstructured":"World Health Organization (WHO). Meeting of the Strategic Advisory Group of Experts on Immunization\u2014conclusions and recommendations. Geneva: WHO, 2013. http:\/\/www.who.int\/wer\/2014\/wer8901.pdf?ua=1 . Accessed 7 July 2016."},{"key":"2017011017160970000_jiw492v1.9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255006"},{"key":"2017011017160970000_jiw492v1.10","unstructured":"World Health Organization (WHO). Draft protocol for notification, risk assessment and response following detection of poliovirus type 2 following globally coordinated cessation of serotype 2 containing oral polio vaccine. Geneva: WHO, 2014. http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/6_Type_2_response_protocol_14_oct_clean.pdf . Accessed 6 April 2016."},{"key":"2017011017160970000_jiw492v1.11","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.vaccine.2015.02.013","article-title":"Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses","volume":"33","author":"Thompson","year":"2015","journal-title":"Vaccine"},{"key":"2017011017160970000_jiw492v1.12","unstructured":"World Health Organization (WHO). Countries using and planning to introduce IPV and the global status of bOPV registration\u2014as of 3 May 2016. Geneva: WHO. http:\/\/www.who.int\/immunization\/diseases\/poliomyelitis\/endgame_objective2\/en\/ . Accessed 7 June 2016."},{"key":"2017011017160970000_jiw492v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu128"},{"key":"2017011017160970000_jiw492v1.14","unstructured":"UNICEF Supply Division. Inactivated poliovirus vaccine supply alert. 2016. http:\/\/www.unicef.org\/supply\/files\/IPV_no._5_Supply_Alert_Update.pdf . Accessed 20 August 2016."},{"key":"2017011017160970000_jiw492v1.15","unstructured":"UNICEF Supply Division. Inactivated polio vaccine supply update. May 2015. http:\/\/www.unicef.org\/supply\/files\/IPV_supply_update_May_2015.pdf . Accessed 20 August 2016."},{"key":"2017011017160970000_jiw492v1.16","unstructured":"Sixty-Eighth World Health Assembly (WHA) A68\/21. Geneva: WHA, 2015. http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_21-en.pdf . Accessed 9 July 2015."},{"key":"2017011017160970000_jiw492v1.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909383"},{"key":"2017011017160970000_jiw492v1.18","doi-asserted-by":"publisher","DOI":"10.1086\/651611"},{"key":"2017011017160970000_jiw492v1.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202541"},{"key":"2017011017160970000_jiw492v1.20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"2017011017160970000_jiw492v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70190-6"},{"key":"2017011017160970000_jiw492v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.104"},{"key":"2017011017160970000_jiw492v1.23","unstructured":"World Health Organization (WHO). Meeting of the Strategic Advisory Group of Experts on Immunization\u2014conclusions and recommendations. Geneva: WHO, 2012. http:\/\/www.who.int\/wer\/2012\/wer8721.pdf?ua=1 . Accessed 7 July 2016."},{"key":"2017011017160970000_jiw492v1.24","unstructured":"R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. http:\/\/www.R-project.org\/ . Accessed 8 February 2015."},{"key":"2017011017160970000_jiw492v1.25","doi-asserted-by":"crossref","unstructured":"Efron B , Tibshirani RJ . An introduction to the bootstrap. 2nd ed. Florida, USA: CRC Press LLC. 1993.","DOI":"10.1007\/978-1-4899-4541-9"},{"key":"2017011017160970000_jiw492v1.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.87802"},{"key":"2017011017160970000_jiw492v1.27","unstructured":"Vidor E , Plotkin SA . Vaccine: poliovirus vaccine\u2014inactivated. In: Plotkin S , Orenstein WA , Offitt PA , eds. Hong Kong, China: Elsevier Saunders, 2013:573\u20139."},{"key":"2017011017160970000_jiw492v1.28","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"2017011017160970000_jiw492v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.10.002"}],"container-title":["Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T21:14:27Z","timestamp":1498338867000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiw492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":29,"alternative-id":["10.1093\/infdis\/jiw492"],"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiw492","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}